Fresenius Medical Care AG & Co. KGaA - FMS Stock Forecast, Price & News

11 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Fresenius Medical Care AG & Co. KGaA in the last twelve months. There are currently 1 sell rating, 7 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" FMS shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in FMS, but not buy additional shares or sell existing shares.
View FMS analyst ratings or view top-rated stocks.

11 brokerages have issued twelve-month target prices for Fresenius Medical Care AG & Co. KGaA's stock. Their FMS share price forecasts range from $23.00 to $72.00. On average, they anticipate the company's stock price to reach $45.83 in the next year. This suggests a possible upside of 142.8% from the stock's current price.
View analysts price targets for FMS or view top-rated stocks among Wall Street analysts.

Fresenius Medical Care AG & Co. KGaA's stock was trading at $32.46 at the beginning of 2022. Since then, FMS stock has decreased by 41.8% and is now trading at $18.88.
View the best growth stocks for 2022 here.

Fresenius Medical Care AG & Co. KGaA saw a decrease in short interest in July. As of July 31st, there was short interest totaling 1,010,000 shares, a decrease of 9.0% from the July 15th total of 1,110,000 shares. Based on an average daily volume of 790,600 shares, the days-to-cover ratio is presently 1.3 days.
View Fresenius Medical Care AG & Co. KGaA's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 1st 2022.
View our FMS earnings forecast.

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) released its earnings results on Tuesday, November, 2nd. The company reported $0.55 EPS for the quarter, meeting analysts' consensus estimates of $0.55. The firm earned $5.24 billion during the quarter, compared to the consensus estimate of $5.37 billion. Fresenius Medical Care AG & Co. KGaA had a net margin of 4.42% and a trailing twelve-month return on equity of 6.70%.

Fresenius Medical Care AG & Co. KGaA announced an annual dividend on Friday, April 29th. Investors of record on Monday, May 16th will be given a dividend of $0.7093 per share on Friday, May 27th. This represents a yield of 3.4%. The ex-dividend date of this dividend is Friday, May 13th.
Read our dividend analysis for FMS.

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) pays an annual dividend of $0.49 per share and currently has a dividend yield of 2.60%. The dividend payout ratio is 31.21%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, FMS will have a dividend payout ratio of 26.34% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for FMS.

Based on aggregate information from My MarketBeat watchlists, some companies that other Fresenius Medical Care AG & Co. KGaA investors own include Energy Transfer (ET), Petra Diamonds (PDL), AT&T (T), Pfizer (PFE), AbbVie (ABBV), Gilead Sciences (GILD), Merck & Co., Inc. (MRK), Abbott Laboratories (ABT), Chevron (CVX) and Ford Motor (F).

Fresenius Medical Care AG & Co. KGaA trades on the New York Stock Exchange (NYSE) under the ticker symbol "FMS."

Fresenius Medical Care AG & Co. KGaA's stock is owned by many different institutional and retail investors. Top institutional investors include Pzena Investment Management LLC (2.25%), Cambiar Investors LLC (0.18%), Tweedy Browne Co LLC (0.17%), Envestnet Asset Management Inc. (0.04%), Clearbridge Investments LLC (0.04%) and Timber Creek Capital Management LLC (0.03%).

Shares of FMS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of FMS stock can currently be purchased for approximately $18.88.

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) has a market capitalization of $11.06 billion and generates $20.85 billion in revenue each year. The company earns $1.15 billion in net income (profit) each year or $1.57 on an earnings per share basis.

The company employs 122,909 workers across the globe.

Fresenius Medical Care AG & Co. KGaA was founded in 1912.

Fresenius Medical Care AG & Co. KGaA's mailing address is ELSE-KROENER STRASSE 1, BAD HOMBURG 2M, 61352. The official website for the company is www.freseniusmedicalcare.com. The company can be reached via phone at (496) 172-6090, via email at ir@fmc-ag.com, or via fax at 49-6172-609-2301.